News
-
-
PRESS RELEASE
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
Sanofi's lunsekimig meets primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP, showing promising results for managing respiratory diseases -
-
PRESS RELEASE
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Positive results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented at AAD Annual Meeting, showing progressive efficacy with Q12W dosing potential -
-
-
PRESS RELEASE
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
Sanofi's Sarclisa subcutaneous formulation via on-body injector recommended for EU approval by CHMP for multiple myeloma treatment, offering innovative delivery. Final decision expected soon -
-
-
